GSK plc
GSK37.430USD
-0.070-0.19%
收盘 04/25, 16:00（美东）报价延迟15分钟
77.58B总市值
23.79市盈率 TTM
关于 GSK plc 公司
GSK plc 是一家全球性生物制药公司。该公司的部门包括商业运营和研发。该公司为卵巢癌、子宫内膜癌和多发性骨髓瘤等患者开发抗癌药物。其产品领域包括疫苗、特种药物和普通药物。该公司还专注于解决呼吸系统和炎症患者尚未满足的治疗需求。其疫苗组合包括 20 多种疫苗，可帮助保护人们免受一系列疾病和感染，包括脑膜炎、带状疱疹和流感等。其特种药物部门还致力于开发用于呼吸系统疾病和艾滋病毒的药物。其普通药物包括用于哮喘和慢性阻塞性肺病的吸入药物、抗生素和用于皮肤病的药物。该公司正在推进慢性乙型肝炎和脂肪肝以及肝病以外其他治疗领域的寡核苷酸疗法。
公司简介
公司代码GSK
公司名称GSK plc
上市日期May 22, 1972
成立日期1999
CEOMs. Deborah Waterhouse
员工数量68629
证券类型Ordinary Share
年结日May 22
公司地址980 Great West Road
城市BRENTFORD
上市交易所London Stock Exchange
国家United Kingdom
邮编TW8 9GS
电话442080475000
网址https://www.gsk.com/
公司代码GSK
上市日期May 22, 1972
成立日期1999
公司高管
名称
名称/职务
职务
持股
持股变动
Dr. Hal V. Barron, M.D.
Dr. Hal V. Barron, M.D.
Non-Executive Director
Non-Executive Director
644.04K
--
Ms. Shobie Ramakrishnan
Ms. Shobie Ramakrishnan
Chief Digital and Technology Officer
Chief Digital and Technology Officer
483.75K
+7.69%
Mr. Charles A. (Charlie) Bancroft
Mr. Charles A. (Charlie) Bancroft
Senior Independent Non-Executive Director
Senior Independent Non-Executive Director
34.31K
+0.51%
Dr. Jesse Goodman, M.D.
Dr. Jesse Goodman, M.D.
Non-Executive Independent Director, Scientific and Medical Expert
Non-Executive Independent Director, Scientific and Medical Expert
15.98K
+0.14%
Ms. Elizabeth McKee (Liz) Anderson
Ms. Elizabeth McKee (Liz) Anderson
Independent Non-Executive Director
Independent Non-Executive Director
2.45K
+1.07%
Dr. Jeannie Lee
Dr. Jeannie Lee
Independent Non-Executive Director and Scientific & Medical Expert
Independent Non-Executive Director and Scientific & Medical Expert
1.05K
+0.96%
Dr. Harry C. (Hal) Dietz
Dr. Harry C. (Hal) Dietz
Independent Non-Executive Director, Scientific and Medical Expert
Independent Non-Executive Director, Scientific and Medical Expert
--
--
Mr. James Ford
Mr. James Ford
Senior Vice President, Group General Counsel, Legal and Compliance
Senior Vice President, Group General Counsel, Legal and Compliance
--
--
Ms. Sally Jackson
Ms. Sally Jackson
Senior Vice President - Global Communications and CEO Office
Senior Vice President - Global Communications and CEO Office
--
--
Dr. Tony Wood, Ph.D.
Dr. Tony Wood, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Dr. Hal V. Barron, M.D.
Dr. Hal V. Barron, M.D.
Non-Executive Director
Non-Executive Director
644.04K
--
Ms. Shobie Ramakrishnan
Ms. Shobie Ramakrishnan
Chief Digital and Technology Officer
Chief Digital and Technology Officer
483.75K
+7.69%
Mr. Charles A. (Charlie) Bancroft
Mr. Charles A. (Charlie) Bancroft
Senior Independent Non-Executive Director
Senior Independent Non-Executive Director
34.31K
+0.51%
Dr. Jesse Goodman, M.D.
Dr. Jesse Goodman, M.D.
Non-Executive Independent Director, Scientific and Medical Expert
Non-Executive Independent Director, Scientific and Medical Expert
15.98K
+0.14%
Ms. Elizabeth McKee (Liz) Anderson
Ms. Elizabeth McKee (Liz) Anderson
Independent Non-Executive Director
Independent Non-Executive Director
2.45K
+1.07%
Dr. Jeannie Lee
Dr. Jeannie Lee
Independent Non-Executive Director and Scientific & Medical Expert
Independent Non-Executive Director and Scientific & Medical Expert
1.05K
+0.96%
收入明细
单位: USD更新时间: 4月6日 周日
单位: USD更新时间: 4月6日 周日
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
业务USD
名称
营收
占比
Respiratory
9.22B
22.99%
HIV
9.06B
22.59%
Shingles
4.30B
10.72%
Established Vaccines
4.27B
10.64%
Immuno-inflammation
4.21B
10.51%
Other
9.04B
22.54%
地区USD
名称
营收
占比
US
20.93B
52.22%
Rest of world
18.25B
45.53%
UK
904.53M
2.26%
业务
地区
业务USD
名称
营收
占比
Respiratory
9.22B
22.99%
HIV
9.06B
22.59%
Shingles
4.30B
10.72%
Established Vaccines
4.27B
10.64%
Immuno-inflammation
4.21B
10.51%
Other
9.04B
22.54%
股东统计
更新时间: 2月21日 周五
更新时间: 2月21日 周五
持股股东
股东类型
持股股东
股东统计
占比
Dodge & Cox
3.33%
Fidelity Management & Research Company LLC
2.13%
PRIMECAP Management Company
1.23%
Fisher Investments
0.92%
JTC Employer Solutions Trusteee Ltd
0.74%
Other
91.66%
持股股东
股东统计
占比
Dodge & Cox
3.33%
Fidelity Management & Research Company LLC
2.13%
PRIMECAP Management Company
1.23%
Fisher Investments
0.92%
JTC Employer Solutions Trusteee Ltd
0.74%
Other
91.66%
股东类型
股东统计
占比
Investment Advisor
8.78%
Investment Advisor/Hedge Fund
6.23%
Hedge Fund
0.93%
Research Firm
0.71%
Bank and Trust
0.09%
Individual Investor
0.06%
Pension Fund
0.06%
Insurance Company
0.06%
Family Office
0.02%
Other
83.06%
机构持股
更新时间: 1月19日 周日
更新时间: 1月19日 周日
报告期
机构数
持股数
持股占比
持股变动
2025Q1
1444
354.89M
17.21%
+26.92M
2024Q4
1481
355.06M
17.14%
+27.38M
2024Q3
1472
319.97M
15.44%
-30.07M
2024Q2
1585
322.06M
15.54%
-29.11M
2024Q1
1617
318.91M
15.39%
-23.52M
2023Q4
1614
299.81M
14.57%
-35.71M
2023Q3
1570
293.92M
14.35%
-37.46M
2023Q2
1545
286.58M
13.99%
-41.88M
2023Q1
1546
281.08M
13.72%
-55.01M
2022Q4
1546
286.90M
13.32%
-22.15M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Dodge & Cox
68.44M
3.32%
+353.75K
+0.52%
Dec 31, 2024
Fidelity Management & Research Company LLC
43.77M
2.12%
+18.14M
+70.76%
Dec 31, 2024
PRIMECAP Management Company
25.26M
1.22%
+10.41M
+70.07%
Dec 31, 2024
Fisher Investments
18.84M
0.91%
+259.87K
+1.40%
Dec 31, 2024
JTC Employer Solutions Trusteee Ltd
20.28M
0.98%
-202.40K
-0.99%
Dec 31, 2024
Fidelity Institutional Asset Management
9.05M
0.44%
+5.68M
+168.17%
Dec 31, 2024
Goldman Sachs Asset Management, L.P.
8.85M
0.43%
+1.77M
+25.04%
Dec 31, 2024
T. Rowe Price International Ltd
7.57M
0.37%
+35.11K
+0.47%
Dec 31, 2024
State Street Global Advisors (US)
7.03M
0.34%
+247.17K
+3.65%
Dec 31, 2024
UBS Financial Services, Inc.
6.34M
0.31%
+5.69M
+871.38%
Dec 31, 2024
查看更多
持股ETF
更新时间: 4月6日 周日
更新时间: 4月6日 周日
机构名称
占比
The Opal International Dividend Income ETF
6.71%
VanEck Pharmaceutical ETF
4.7%
Keating Active ETF
3.52%
Brandes International ETF
3.27%
Sound Equity Dividend Income ETF
3.17%
Altrius Global Dividend ETF
1.9%
Pacer Global Cash Cows Dividend ETF
1.87%
USCF Dividend Income Fund
1.59%
Fidelity Blue Chip Value ETF
1.4%
Fidelity Women's Leadership ETF
1.08%
查看更多
The Opal International Dividend Income ETF
占比6.71%
VanEck Pharmaceutical ETF
占比4.7%
Keating Active ETF
占比3.52%
Brandes International ETF
占比3.27%
Sound Equity Dividend Income ETF
占比3.17%
Altrius Global Dividend ETF
占比1.9%
Pacer Global Cash Cows Dividend ETF
占比1.87%
USCF Dividend Income Fund
占比1.59%
Fidelity Blue Chip Value ETF
占比1.4%
Fidelity Women's Leadership ETF
占比1.08%
分红派息
近5年累计派现
20.79B
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
Feb 05, 2025
GSK.NB Approximate interim Cash Dividend of gross USD 0.400652 paid on Apr 10, 2025 going ex on Feb 21, 2025
Feb 21, 2025
Apr 10, 2025
Feb 21, 2025
Oct 30, 2024
GSK.NB Final Cash Dividend of gross USD 0.376892 paid on Jan 09, 2025 going ex on Nov 15, 2024
Nov 15, 2024
Jan 09, 2025
Nov 15, 2024
Jul 31, 2024
GSK.NB Interim Cash Dividend of gross USD 0.392813 paid on Oct 10, 2024 going ex on Aug 16, 2024
Aug 16, 2024
Oct 10, 2024
Aug 16, 2024
May 01, 2024
GSK.NB Interim Cash Dividend of gross USD 0.384301 paid on Jul 11, 2024 going ex on May 16, 2024
May 17, 2024
Jul 11, 2024
May 16, 2024
Feb 01, 2024
GSK.NB Interim Cash Dividend of gross USD 0.404885 paid on Apr 11, 2024 going ex on Feb 22, 2024
Feb 23, 2024
Apr 11, 2024
Feb 22, 2024
Nov 01, 2023
GSK.NB Final Cash Dividend of gross USD 0.356356 paid on Jan 11, 2024 going ex on Nov 16, 2023
Nov 17, 2023
Jan 11, 2024
Nov 16, 2023
Jul 26, 2023
GSK.NB Interim Cash Dividend of gross USD 0.343532 paid on Oct 12, 2023 going ex on Aug 17, 2023
Aug 18, 2023
Oct 12, 2023
Aug 17, 2023
Apr 26, 2023
GSK.NB Interim Cash Dividend of gross USD 0.360944 paid on Jul 13, 2023 going ex on May 18, 2023
May 19, 2023
Jul 13, 2023
May 18, 2023
Feb 01, 2023
GSK.NB Interim Cash Dividend of gross USD 0.341883 paid on Apr 13, 2023 going ex on Feb 23, 2023
Feb 24, 2023
Apr 13, 2023
Feb 23, 2023
Nov 02, 2022
GSK.NB Final Cash Dividend of gross USD 0.334785 paid on Jan 12, 2023 going ex on Nov 17, 2022
Nov 18, 2022
Jan 12, 2023
Nov 17, 2022
查看更多
拆合股
公告日期
类型
比率
Jun 24, 2022
Merger
5<4
Jun 24, 2022
Merger
5<4
Jun 24, 2022
Merger
5<4
Jun 24, 2022
Merger
5<4
公告日期
类型
比率
Jun 24, 2022
Merger
5<4
Jun 24, 2022
Merger
5<4
Jun 24, 2022
Merger
5<4
Jun 24, 2022
Merger
5<4